MichaelScottRutenbergMDPhD

Gastrointestinal Cancer, Sarcoma

Senior Associate Consultant, Radiation Oncology, Mayo Clinic Florida

Dr. Rutenberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
4500 San Pablo Road South
Jacksonville, FL 32224
Phone+1 904-953-2000

PubMed

Advancements in Locoregional Therapies for Unresectable Intrahepatic Cholangiocarcinoma.
Conor D J O'Donnell, Umair Majeed, Michael S Rutenberg, Kristopher P Croome, Katherine E Poruk
Current Oncology. 2025-01-31
A multi-institutional retrospective cohort of adult-onset medulloblastoma in the modern era.
Alipi V Bonm, Michael S Rutenberg, Kate E Therkelsen, John Herbst, Anurag Sanaf
Neuro-Oncology Advances. 2025-01-22
Evaluating Tumor Tissue Modified Viral (TTMV)-HPV DNA for the Early Detection of Anal Squamous Cell Carcinoma Recurrence.
Rafi Kabarriti, Shane Lloyd, James Jabalee, Catherine Del Vecchio Fitz, Randa Tao
Cancers. 2025-01-08

Journal Articles

Prognostic Factors of Radiation Dermatitis Following Passive-Scattering Proton Therapy for Breast Cancer
Nancy Mendenhall, Julie A Bradley, Daniel Yeung, Michael Rutenberg, BioMed Central

$Preoperative Hypofractionated Radiotherapy with FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma (PHOX)$
Preoperative Hypofractionated Radiotherapy with FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma (PHOX)October 13th, 2023